Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.8.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.54.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.30.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.55.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.18.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.144NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.288NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.249NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.378NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.97NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.439NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.408NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.256NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.7 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.460NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.262NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBUNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.351.5 (Beta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FZ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.9.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.30.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used